Net Profit (excluding exceptional items) at Rs 140 Cr - Biocon

Profit Before Tax and Exceptional Items stood at Rs 246 crore compared to Rs 269 crore during the same quarter last fiscal. This decline is due to higher interest and amortisation costs …

CouponFollow Extension

96%
OFF

Biocon Q3 Results: Profit Plummets 96%; Misses Estimates

2 weeks from now

Jan 30, 2025 · Biocon Ltd.'s Q3FY25 consolidated net profit plummeted 96% to Rs 25 crore, falling short of analysts' estimates. Revenue declined 3.4% to Rs 3,821 crore. Biocon Ltd.'s …

ndtvprofit.com

30%
OFF

Biocon Q3 Results: Rs 42-Crore Loss Due To One-Offs - NDTV Profit

2 weeks from now

Feb 14, 2023 · Biocon's Q3 operating profit rose 30% to Rs 634 crore, while revenue surged 35% to Rs 2,941 crore. ... The company said its net profit, excluding exceptional items, stood at Rs …

ndtvprofit.com

7%
OFF

Biocon Q3FY25 Revenue At Rs 3,856 Cr, Up 7%# EBITDA At Rs 787 …

2 weeks from now

Jan 30, 2025 · Net R&D investments for the quarter were Rs 199 crore, representing 7% of revenue ex-Syngene. EBITDA for the quarter stood at Rs 787 crore, Up 16% on a like for like …

bioconbiologics.com

57%
OFF

Biocon Q4 Results: Net Profit Falls 57% To Rs 136 Crore; Revenue Up …

2 weeks from now

May 16, 2024 · Biocon Q4 results: Net profit falls 57% to Rs 136 crore; revenue up 0.94% ... Consolidated net profit before exceptional items for the fourth quarter of FY24 stood at Rs 144 …

business-standard.com

21%
OFF

Biocon Q4FY22 Revenue At Rs 2,476 Cr, Up 21%; Core EBITDA At …

2 weeks from now

Apr 28, 2022 · FY22 Net Profit before Exceptional Items was Rs 722 Crore (vs. Rs 744 Crore in FY21) FY22 Net Proﬁt # at Rs 648 Crore (vs. Rs 740 Crore in FY21) # Adjusted for dilution …

bioconbiologics.com

26%
OFF

Biocon Q4FY19 Revenue Rs 1,557 Cr, Up 26%; EBITDA Up 43

2 weeks from now

Net Profit (including exceptional income*) for the year climbed 143% to Rs 905 Crore. Net Profit (excluding exceptional income*) stood at Rs 729 Crore reflecting a stellar growth of 96%. Net …

biocon.com

10%
OFF

Biocon Q2FY22 Revenue Up 10% At Rs 1,945 Cr; EBITDA Up 35% At …

2 weeks from now

Oct 21, 2021 · Biocon Q2FY22 Revenue up 10% at Rs 1,945 Cr; EBITDA up 35% at Rs 551 Cr; Net Profit (before exceptional items) up 11% at Rs 188 Cr; Fri, 22-Oct-2021 Posted by: Biocon …

bioconbiologics.com

36%
OFF

Biocon Q3FY23 Revenue At Rs 3,020 Cr, Up 36%; Biosimilars Up …

2 weeks from now

Mar 9, 2023 · EBITDA at Rs 723 Cr, Up 35%; Core EBITDA at Rs 1,069 Cr, Up 49%; Net Profit (excluding exceptional items) at Rs 140 Cr Bengaluru, Karnataka, India: February 14, 2023: …

bioconbiologics.com

38%
OFF

FY23 Revenue At Rs 11,550 Cr, Up 38%; EBITDA At Rs 2,888 Cr …

2 weeks from now

May 23, 2023 · 5 EBITDA for the quarter increases 75% to Rs 1,152 crore, representing an EBITDA margin of 29% versus 27% in the same period last year. Profit Before Tax and …

biocon.com

36%
OFF

Biocon Q3FY23 Revenue At Rs 3,020 Cr, Up 36%; Biosimilars Up …

2 weeks from now

Feb 14, 2023 · EBITDA at Rs 723 Cr, Up 35%; Core EBITDA at Rs 1,069 Cr, Up 49%; Net Profit (excluding exceptional items) at Rs 140 Cr Bengaluru, Karnataka, India: February 14, 2023: …

biocon.com

10%
OFF

Biocon Q2FY22 Revenue Up 10% At Rs 1,945 Cr; EBITDA Up 35% At …

2 weeks from now

Oct 21, 2021 · Net Profit for Q2FY22, before such exceptional items, was Rs 188 Crore, up 11%. Our Core EBITDA margins for the quarter were at a healthy 33%. “Biocon Biologics made …

biocon.com

FAQs about Net Profit (excluding exceptional items) at Rs 140 Cr - Biocon Coupon?

How did Biocon perform in fiscal 2024?

Biocon Ltd. reported a consolidated net profit in the third quarter of fiscal 2024, beating analysts' estimates. The drugmaker had a profit of Rs 753 crore in the October-December quarter, as against a loss of Rs 21 crore over the same period last year, according to an exchange filing on Thursday. ...

How will Biocon's R&D investments drive its future growth?

Biocon reported Research Services revenues of Rs 786 crore and Generics business revenues of Rs 718 crore, which grew 23% and 18%, respectively. Net R&D investments amounted to Rs 337 crore this quarter, driven by the advancement of Biocon’s research pipeline. ...

What was consolidated net profit before exceptional items in fy24?

Consolidated net profit before exceptional items for the fourth quarter of FY24 stood at Rs 144 crore. It was Rs 335 crore in the same quarter of the previous year. This was also way lower than the consensus estimate of Rs 164.3 crore, according to Bloomberg. ...

What is Biocon's fourth-quarter net profit in 2022-23?

Bengaluru-based biotech firm Biocon has posted a 31 per cent rise in fourth-quarter net profit to Rs 313 crore in 2022-23. This is compared to Rs 239 crore during the same period in 2021-22. ...

Why did Biocon Group grow 58% to Rs 824 crore?

This growth was largely driven by Biosimilars which grew 58% to Rs 8,824 crore. “The Biocon Group has strengthened business operations, expanded global reach and is now increasingly well positioned to deliver a new phase of growth spanning Biosimilars, GLP-1 peptides and CDMO services. ...

Why did Biocon raise funds?

We reported a strong EBITDA growth of 35% to Rs 723 crore, representing a healthy EBITDA margin of 24%. Core EBITDA grew 49% to Rs 1,069 crore. As a part of our strategy to reduce the acquisition debt, Biocon has raised funds through a partial divestment of its stake in Syngene. ...